A review of screening strategies for cervical cancer in human immunodeficiency virus-positive women in sub-Saharan Africa
- PMID: 28203108
- PMCID: PMC5298303
- DOI: 10.2147/IJWH.S103868
A review of screening strategies for cervical cancer in human immunodeficiency virus-positive women in sub-Saharan Africa
Abstract
Cervical cancer (CC) is a leading cause of cancer-related death and a major public health issue in sub-Saharan Africa. This heavy burden parallels that of the human immunodeficiency virus (HIV) infection, which increases the risk of developing CC. Despite the progressive reduction of HIV prevalence in the past decade, the CC incidence and mortality rates in sub-Saharan Africa remain high. The heterogeneity of the distribution of the two diseases in the African continent, together with the different availability of human and material resources, stands in the way of finding an appropriate screening strategy. The lack of high-quality evidence on the prevention of CC for HIV-positive women, which is necessary for the implementation of efficient screening and treatment strategies, results in the absence of a clearly defined program, which is responsible for the low screening uptake and high mortality rates in sub-Saharan Africa. By taking advantage of the HIV-positive women's frequent access to health facilities, one way to increase the CC screening coverage rates would be by providing integrated HIV and screening services within the same infrastructure. With the increasing availability of cost-effective methods, screening is becoming more and more available to women who have limited access to health care. Moreover, the introduction of point-of-care technologies for human papillomavirus testing and the subsequent implementation of screen-and-treat strategies, by reducing the number of clinical appointments and, in the long term, the loss to follow-up rates, open up new opportunities for all women, regardless of their HIV status. The purpose of this review is to provide an insight into the different screening practices for CC in order to help define one that is adapted to the resources and necessities of HIV-positive women living in middle-to-low income countries.
Keywords: cervical cancer; human immunodeficiency virus (HIV); human papillomavirus (HPV); screening.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Tuberculosis.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
-
Uptake and barriers to cervical cancer screening among human immunodeficiency virus-positive women in Sub Saharan Africa: a systematic review and meta-analysis.BMC Womens Health. 2023 Jun 27;23(1):338. doi: 10.1186/s12905-023-02479-w. BMC Womens Health. 2023. PMID: 37370091 Free PMC article.
-
Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.Vaccine. 2013 Dec 29;31 Suppl 5:F47-52. doi: 10.1016/j.vaccine.2012.06.066. Vaccine. 2013. PMID: 24331747 Review.
-
[Current status of the female condom in Africa].Sante. 1997 Nov-Dec;7(6):405-15. Sante. 1997. PMID: 9503499 Review. French.
-
Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.J Low Genit Tract Dis. 2019 Apr;23(2):87-101. doi: 10.1097/LGT.0000000000000468. J Low Genit Tract Dis. 2019. PMID: 30907775
Cited by
-
Predictors of cervical cancer screening among Kenyan women: results of a nested case-control study in a nationally representative survey.BMC Public Health. 2018 Nov 7;18(Suppl 3):1221. doi: 10.1186/s12889-018-6054-9. BMC Public Health. 2018. PMID: 30400916 Free PMC article.
-
Screening test accuracy to improve detection of precancerous lesions of the cervix in women living with HIV: a study protocol.BMJ Open. 2020 Dec 18;10(12):e037955. doi: 10.1136/bmjopen-2020-037955. BMJ Open. 2020. PMID: 33371015 Free PMC article.
-
The use of molecular markers for cervical screening of women living with HIV in South Africa.AIDS. 2019 Nov 1;33(13):2035-2042. doi: 10.1097/QAD.0000000000002325. AIDS. 2019. PMID: 31385866 Free PMC article.
-
Integrating HIV services and other health services: A systematic review and meta-analysis.PLoS Med. 2021 Nov 9;18(11):e1003836. doi: 10.1371/journal.pmed.1003836. eCollection 2021 Nov. PLoS Med. 2021. PMID: 34752477 Free PMC article.
-
Utilisation of cervical cancer screening among women living with HIV at Kenya's national referral hospital.South Afr J HIV Med. 2022 Apr 25;23(1):1353. doi: 10.4102/sajhivmed.v23i1.1353. eCollection 2022. South Afr J HIV Med. 2022. PMID: 35706549 Free PMC article.
References
-
- Ngono G, Evina F. Enquête Démographique et de Santé et Indicateurs Multiples du Cameroun. Claverton, Maryland, USA: INS & ICF International; 2011.
-
- Catarino R, Vassilakos P, Tebeu PM, Schafer S, Bongoe A, Petignat P. Risk factors associated with human papillomavirus prevalence and cervical neoplasia among Cameroonian women. Cancer Epidemiol. 2016;40:60–66. - PubMed
-
- data.worldbank.org [homepage on the Internet] The World Bank Group; 2016. [Accessed September 29, 2016]. Available from: http://data.worldbank.org/indicator/SH.DYN.AIDS.ZS.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous